Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Sep. 30, 2020	$ 146	$ 40,472,229	$ (34,272,778)	$ 190,161	$ 6,389,758
Beginning balance, shares at Sep. 30, 2020	14,570,105
Stock option expense		4,507,298			4,507,298
Other comprehensive loss				1,656	1,656
Net loss			(5,896,072)		(5,896,072)
Exercise of stock options		9,180			9,180
Exercise of stock options, shares	6,000
Equity securities issued for cash, net of issuance costs	$ 3	2,683,977			2,683,980
Equity securities issued for cash, shares	324,959
Ending balance, value at Dec. 31, 2020	$ 149	47,672,684	(40,168,850)	191,817	7,695,800
Ending balance, shares at Dec. 31, 2020	14,901,064
Beginning balance, value at Sep. 30, 2020	$ 146	40,472,229	(34,272,778)	190,161	6,389,758
Beginning balance, shares at Sep. 30, 2020	14,570,105
Other comprehensive loss					(2,374)
Net loss					(15,048,722)
Ending balance, value at Jun. 30, 2021	$ 178	63,147,614	(49,321,500)	187,787	14,014,079
Ending balance, shares at Jun. 30, 2021	17,820,390
Beginning balance, value at Dec. 31, 2020	$ 149	47,672,684	(40,168,850)	191,817	7,695,800
Beginning balance, shares at Dec. 31, 2020	14,901,064
Stock option expense		1,989,006			1,989,006
Other comprehensive loss				3,824	3,824
Net loss			(6,085,608)		(6,085,608)
Restricted stock award issuance	$ 1	870,999			871,000
Restricted stock award issuance, shares	137,215
Equity securities issued for cash, net of issuance costs	$ 28	11,017,276			11,017,304
Equity securities issued for cash, shares	2,782,111
Ending balance, value at Mar. 31, 2021	$ 178	61,549,965	(46,254,458)	195,641	15,491,326
Ending balance, shares at Mar. 31, 2021	17,820,390
Stock option expense		1,506,613			1,506,613
Other comprehensive loss				(7,854)	(7,854)
Net loss			(3,067,042)		(3,067,042)
Amortization of restricted stock award issued		91,036			91,036
Ending balance, value at Jun. 30, 2021	$ 178	63,147,614	(49,321,500)	187,787	14,014,079
Ending balance, shares at Jun. 30, 2021	17,820,390
Beginning balance, value at Sep. 30, 2021	$ 178	64,839,254	(52,824,808)	197,823	12,212,447
Beginning balance, shares at Sep. 30, 2021	17,820,390
Exercise of warrants, net of issuance costs	$ 4	1,721,014			1,721,018
Exercise of warrants, shares	384,447
Stock option expense		1,124,187			1,124,187
Other comprehensive loss				32,688	32,688
Net loss			(2,804,203)		(2,804,203)
Ending balance, value at Dec. 31, 2021	$ 182	67,684,455	(55,629,011)	230,511	12,286,137
Ending balance, shares at Dec. 31, 2021	18,204,837
Beginning balance, value at Sep. 30, 2021	$ 178	64,839,254	(52,824,808)	197,823	12,212,447
Beginning balance, shares at Sep. 30, 2021	17,820,390
Other comprehensive loss					(19,604)
Net loss					$ (8,661,792)
Exercise of stock options, shares					14,000
Ending balance, value at Jun. 30, 2022	$ 194	71,485,715	(61,486,600)	178,219	$ 10,177,528
Ending balance, shares at Jun. 30, 2022	19,468,017
Beginning balance, value at Dec. 31, 2021	$ 182	67,684,455	(55,629,011)	230,511	12,286,137
Beginning balance, shares at Dec. 31, 2021	18,204,837
Stock option expense		935,447			935,447
Other comprehensive loss				(7,095)	(7,095)
Net loss			(3,223,697)		(3,223,697)
Warrant issuance costs		(18,422)			(18,422)
Common stock issued for cash, ATM offering, net of issuance costs		88,426			88,426
Common stock issued for cash, ATM offering, shares	42,448
Common stock issued to settle Dripkit Bulk Sales Holdback Amount	$ 2	386,842			386,844
Common stock issued for Dripkit acquisition, shares	178,681
Exercise of stock options		12,600			12,600
Exercise of stock options, shares	14,000
Restricted stock award issuance	$ 1	9,589			9,590
Restricted stock award issuance, shares	117,920
Ending balance, value at Mar. 31, 2022	$ 185	69,098,937	(58,852,708)	223,416	10,469,830
Ending balance, shares at Mar. 31, 2022	18,557,886
Stock option expense		627,895			627,895
Other comprehensive loss				(45,197)	(45,197)
Net loss			(2,633,892)		(2,633,892)
Common stock issued for cash, ATM offering, net of issuance costs		6,830			6,830
Common stock issued for cash, ATM offering, shares	6,878
Common stock issued to settle Dripkit Bulk Sales Holdback Amount		40,000			40,000
Common stock issued for Dripkit acquisition, shares	18,475
Equity securities issued for cash, net of issuance costs	$ 9	1,649,727			1,649,736
Equity securities issued for cash, shares	884,778
Amortization of restricted stock award issued		62,326			62,326
Ending balance, value at Jun. 30, 2022	$ 194	$ 71,485,715	$ (61,486,600)	$ 178,219	$ 10,177,528
Ending balance, shares at Jun. 30, 2022	19,468,017